Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Glaukos’ iDose TR Hits the Commercial Market
Glaukos Corporation’s iDose TR, using Celanese’s VitalDose EVA (Ethylene Vinyl Acetate), to provide sustained drug release for the treatment of glaucoma has officially entered the commercial market. Having received FDA approval in December, iDose TR represents a notable departure from…
Study Uncovers Eye’s Defense Against Brain Infections
In a study published in the journal Nature, researchers have found that vaccines injected into the eyes of mice can effectively combat the herpes virus, a leading cause of brain encephalitis. Contrary to expectations, the vaccine triggers an immune response…
CorNeat Vision Introduces CorNeat EverPatch in the U.S.
CorNeat Vision has launched the CorNeat EverPatch in the United States, a novel synthetic tissue-integrating matrix poised to transform ophthalmic surgeries. Endorsed by leading surgeons across the US, this FDA-cleared device marks a significant advancement in addressing complications associated with…
Study Finds Link Between Gut Bacteria and Inherited Eye Diseases
Researchers from University College London and Moorfields Eye Hospital have discovered a link between gut bacteria and vision loss in some inherited eye diseases. This pioneering research, conducted on mice, suggests that antimicrobial treatment might offer a new avenue for…
Optos Celebrates Worldwide Installations & Clinical Studies
Optos PLC celebrates two significant achievements: the global installation of over 25,000 devices and the accomplishment of 2,500 clinical and peer-reviewed studies covering 235 disease states. These milestones underscore Optos’ over three decades of innovation and its substantial impact on elevating…
Amring Names Dr. Donnenfeld as U.S. Advisory Board Chair
Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announced the appointment of Dr. Eric D. Donnenfeld, a distinguished figure in ophthalmology, as the Chair of its U.S. Medical Advisory Board (MAB). This strategic decision comes as the company gears…
AI’s Superiority in Diagnosing Glaucoma & Retinal Diseases
A study conducted at the New York Eye and Ear Infirmary of Mount Sinai (NYEE) demonstrates that a large language model (LLM) AI system, specifically GPT-4 (Generative Pre-Training–Model 4) from OpenAI, can rival, and in some cases surpass, human ophthalmologists…
Ophthalmology In Ancient Egyptian & Greek Mythology I OBN
The Brightness of Divine Glance In Ancient Egypt One of the first civilizations in human history is that of ancient Egypt. The pioneering work of the ancient Egyptians in the domains of art, medicine, and the mythological storytelling of scientific…
Dry Eye Disease in Postmenopausal Women
A common ocular problem is dry eye syndrome. Women are more likely to acquire dry eye syndrome and its accompanying detrimental implications on their general eye health, especially menopausal women with comorbidities. One of the most common ocular disorders is…
Eversight Partners with Emmecell for Ocular Therapy Advances
Eversight, a leading non-profit dedicated to the restoration of sight through the recovery, processing, and distribution of corneal tissue, announced a strategic partnership with Emmecell Biotech, a biotechnology company focused on developing novel cell therapies for ocular diseases. This collaboration…